Next-ChemX Corporation (CHMX) Stock
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Next-ChemX Corporation
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.
Next-ChemX Corporation (CHMX) stock trades at $0.00 with a market capitalization of $14273. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $5.75, and currently trades 100.0% below its 52-week high.
On profitability, Next-ChemX Corporation generates a return on equity (ROE) of 66.67% — well above the market average, a sign of a high-quality business, return on capital employed of 46.27%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.next-chemx.com